Promotion and selection by serum growth factors drive field cancerization, which is anticipated in vivo by type 2 diabetes and obesity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 34, 2013, Pages 13927-13931

  Rubin, Harry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hyperinsulinemia; Neoplastic transformation; Preneoplasia

Indexed keywords

INSULIN; MAGNESIUM; SOMATOMEDIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL GROWTH; CELL STRAIN 3T3; GROWTH HORMONE BLOOD LEVEL; HYPERINSULINEMIA; HYPOMAGNESEMIA; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL;

HYPERINSULINEMIA; NEOPLASTIC TRANSFORMATION; PRENEOPLASIA;

ANIMALS; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; HYPERINSULINISM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; NIH 3T3 CELLS; OBESITY;

EID: 84882804634     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1312831110     Document Type: Article

References (55)

1. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5):963-968.
2. Lockhart-Mummery JP, Dukes MP (1928) The precancerous changes in the rectum and colon. Surg Gynecol Obstet 46:591-596.
3. Willis RA (1944) The mode of origin of tumors: Solitary localized squamous cell growths of the skin. Cancer Res 4:630-644.
4. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 63(8):1727-1730.
5. Califano J, et al. (1996) Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56(11):2488-2492.
6. Rubin AL, Arnstein P, Rubin H (1990) Physiological induction and reversal of focus formation and tumorigenicity in NIH 3T3 cells. Proc Natl Acad Sci USA 87(24):10005-10009.
7. Taubes G (2012) Cancer research. Unraveling the obesity-cancer connection. Science 335(6064):28-32, 30-32.
8. Petersen KF, et al. (2012) Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes. Proc Natl Acad Sci USA 109(21):8236-8240.
9. Bruce WR, Giacca A, Medline A (2000) Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9(12):1271-1279.
10. Rubin H (1977) Antagonistic effects of insulin and cortisol on coordinate control of metabolism and growth in cultured fibroblasts. J Cell Physiol 91(2):249-259.
11. Sanui H, Rubin AH (1978) Membrane bound and cellular cationic changes associated with insulin stimulation of cultured cells. J Cell Physiol 96(3):265-278.
12. Sridhar SS, Goodwin PJ (2009) Insulin-insulin-like growth factor axis and colon cancer. J Clin Oncol 27(2):165-167.
13. Wideroff L, et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89(18):1360-1365.
14. Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J Nutr 131(11, Suppl):3109S-3120S.
15. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579-591.
16. Tran TT, et al. (2006) Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 147(4):1830-1837.
17. Tran TT, Medline A, Bruce WR (1996) Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5(12):1013-1015.
18. Tran TT, et al. (2003) Direct measure of insulin sensitivity with the hyperinsulinemiceuglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: Correlations with aberrant crypt foci promotion in rats. Cancer Epidemiol Biomarkers Prev 12(1):47-56.
19. Kabat GC, et al. (2012) A longitudinal study of seruminsulin and glucose levels in relation to colorectal cancer risk among postmenopausal women. Br J Cancer 106(1):227-232.
20. Kabat GC, Rohan TE (2012) Is elevated serum insulin a marker of increased risk of colorectal cancer? Colorectal Cancer 1(2):89-92.
21. Gunter MJ, et al. (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68(1):329-337.
22. Khandekar MJ, Cohen P, Spiegelman BM (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11(12):886-895.
23. Odegaard JI, Chawla A (2013) Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339(6116):172-177.
24. Rubin H (2011) Fields and field cancerization: The preneoplastic origins of cancer: Asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture. Bioessays 33(3):224-231.
25. Coman DR (1944) Decreased mutual adhesiveness, a property of cells from squamous cell carcinomas. Cancer Res 4:625-629.
26. Rubin H (2008) Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype. Proc Natl Acad Sci USA 105(17):6215-6221.
27. Temin HM, Rubin H (1958) Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 6(3):669-688.
28. Martin GS (2004) The road to Src. Oncogene 23(48):7910-7917.
29. Farber E (1984) Themultistep nature of cancer development. Cancer Res 44(10):4217-4223.
30. Stratton MR (2011) Exploring the genomes of cancer cells: Progress and promise. Science 331(6024):1553-1558.
31. Varmus HE (1984) The molecular genetics of cellular oncogenes. Annu Rev Genet 18:553-612.
32. Rubin H, Xu K (1989) Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc Natl Acad Sci USA 86(6):1860-1864.
33. Burke MK, et al. (2010) Genome-wide analysis of a long-term evolution experiment with Drosophila. Nature 467(7315):587-590.
34. Grundel R, Rubin H (1988) Maintenance of multiplication rate stability by cell populations in the face of heterogeneity among individual cells. J Cell Sci 91(Pt 4): 571-576.
35. Grundel R, Rubin H (1991) Effect of interclonal heterogeneity on the progressive, confluence-mediated acquisition of the focus-forming phenotype in NIH-3T3 populations. Cancer Res 51(3):1003-1013.
36. Rubin AL, Yao A, Rubin H (1990) Relation of spontaneous transformation in cell culture to adaptive growth and clonal heterogeneity. Proc Natl Acad Sci USA 87(1):482-486.
37. Rubin H (2005) Degrees and kinds of selection in spontaneous neoplastic transformation: An operational analysis. Proc Natl Acad Sci USA 102(26):9276-9281.
38. Krawczak M, et al. (1995) Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection. Hum Mutat 5(1):48-57.
39. Rodin SN, Rodin AS (2000) Human lung cancer and p53: The interplay between mutagenesis and selection. Proc Natl Acad Sci USA 97(22):12244-12249.
40. Schöllnberger H, Beerenwinkel N, Hoogenveen R, Vineis P (2010) Cell selection as driving force in lung and colon carcinogenesis. Cancer Res 70(17):6797-6803.
41. Petersen KF, et al. (2003) Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300(5622):1140-1142.
42. Rubin H, Nomura T (1987) Use of lymph in cell culture to model hormonal and nutritional constraints on tumor growth in vivo. Cancer Res 47(18):4924-4931.
43. Willett WC (2002) Balancing life-style and genomics research for disease prevention. Science 296(5568):695-698.
44. Marx J (2002) Unraveling the causes of diabetes. Science 296(5568):686-689.
45. Paolisso G, Barbagallo M (1997) Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium. Am J Hypertens 10(3):346-355.
46. Humphries S, Kushner H, Falkner B (1999) Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans. Am J Hypertens 12(8 Pt 1):747-756.
47. Takaya J, Higashino H, Kobayashi Y (2004) Intracellular magnesium and insulin resistance. Magnes Res 17(2):126-136.
48. Huerta MG, et al. (2005) Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 28(5):1175-1181.
49. Corica F, et al. (2006) Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 25(3):210-215.
50. Hruby A, et al. (2013) Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a metaanalysis of 15 CHARGE Consortium Studies. J Nutr 143(3):345-353.
51. Paolisso G, Ravussin E (1995) Intracellular magnesium and insulin resistance: Results in Pima Indians and Caucasians. J Clin Endocrinol Metab 80(4):1382-1385.
52. Rubin H (1976) Magnesium deprivation reproduces the coordinate effects of serum removal or cortisol addition on transport and metabolism in chick embryo fibroblasts. J Cell Physiol 89(4):613-625.
53. Aaronson SA, Todaro GJ (1968) Development of 3T3-like lines from Balb-c mouse embryo cultures: Transformation susceptibility to SV40. J Cell Physiol 72(2):141-148.
54. Shipley GD, Ham RG (1981) Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cells. In Vitro 17(8):656-670.
55. Holley RW, Kiernan JA (1968) "Contact inhibition" of cell division in 3T3 cells. Proc Natl Acad Sci USA 60(1):300-304.